A detailed history of Canandaigua National Bank & Trust CO transactions in Becton Dickinson & CO stock. As of the latest transaction made, Canandaigua National Bank & Trust CO holds 4,276 shares of BDX stock, worth $964,409. This represents 0.17% of its overall portfolio holdings.

Number of Shares
4,276
Previous 4,247 0.68%
Holding current value
$964,409
Previous $1.04 Million 2.22%
% of portfolio
0.17%
Previous 0.17%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 01, 2024

BUY
$233.45 - $247.73 $6,770 - $7,184
29 Added 0.68%
4,276 $1.06 Million
Q4 2023

Jan 04, 2024

SELL
$232.24 - $267.23 $231,078 - $265,893
-995 Reduced 18.98%
4,247 $1.04 Million
Q3 2023

Oct 10, 2023

SELL
$254.9 - $283.59 $40,019 - $44,523
-157 Reduced 2.91%
5,242 $1.36 Million
Q2 2023

Jul 03, 2023

BUY
$238.39 - $265.32 $11,442 - $12,735
48 Added 0.9%
5,399 $1.43 Million
Q1 2023

Apr 11, 2023

BUY
$229.71 - $259.35 $431,625 - $487,318
1,879 Added 54.12%
5,351 $1.33 Million
Q1 2020

Apr 16, 2020

SELL
$195.69 - $279.01 $78,080 - $111,324
-399 Reduced 10.31%
3,472 $798,000
Q3 2019

Nov 13, 2019

SELL
$230.58 - $256.08 $7,378 - $8,194
-32 Reduced 0.82%
3,871 $979,000
Q1 2019

Apr 25, 2019

BUY
$206.05 - $248.17 $37,089 - $44,670
180 Added 4.83%
3,903 $975,000
Q4 2018

Feb 06, 2019

SELL
$204.73 - $257.93 $4,094 - $5,158
-20 Reduced 0.53%
3,723 $839,000
Q3 2018

Nov 02, 2018

SELL
$233.07 - $256.0 $69,921 - $76,800
-300 Reduced 7.42%
3,743 $977,000
Q2 2018

Aug 03, 2018

SELL
$208.1 - $233.85 $40,995 - $46,068
-197 Reduced 4.65%
4,043 $969,000
Q1 2018

May 09, 2018

BUY
$205.46 - $240.27 $871,150 - $1.02 Million
4,240 New
4,240 $919,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Canandaigua National Bank & Trust CO Portfolio

Follow Canandaigua National Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canandaigua National Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Canandaigua National Bank & Trust CO with notifications on news.